Parkside Financial Bank & Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348K Sell
4,846
-121
-2% -$9.32K 0.03% 319
2025
Q4
$394K Buy
4,967
+406
+9% +$32K 0.03% 298
2025
Q3
$344K Sell
4,561
-666
-13% -$45.6K 0.03% 320
2025
Q2
$361K Buy
5,227
+123
+2% +$8.07K 0.04% 302
2025
Q1
$346K Buy
5,104
+35
+0.7% +$2.09K 0.04% 277
2024
Q4
$228K Sell
5,069
-531
-9% -$29.8K 0.03% 359
2024
Q3
$352K Buy
5,600
+788
+16% +$46K 0.05% 259
2024
Q2
$284K Sell
4,812
-1,051
-18% -$65.7K 0.04% 281
2024
Q1
$468K Buy
5,863
+172
+3% +$13.1K 0.08% 198
2023
Q4
$449K Sell
5,691
-96
-2% -$6.83K 0.08% 184
2023
Q3
$404K Buy
5,787
+2,032
+54% +$144K 0.09% 161
2023
Q2
$260K Sell
3,755
-996
-21% -$70.9K 0.06% 222
2023
Q1
$353K Buy
4,751
+287
+6% +$24.1K 0.1% 162
2022
Q4
$416K Buy
4,464
+300
+7% +$28.9K 0.12% 137
2022
Q3
$397K Buy
4,164
+310
+8% +$30.7K 0.13% 133
2022
Q2
$357K Buy
3,854
+215
+6% +$21K 0.11% 153
2022
Q1
$368K Buy
3,639
+40
+1% +$4.2K 0.1% 151
2021
Q4
$371K Buy
3,599
+245
+7% +$22.6K 0.09% 159
2021
Q3
$284K Buy
3,354
+264
+9% +$22.1K 0.08% 163
2021
Q2
$258K Buy
3,090
+20
+0.7% +$1.64K 0.07% 170
2021
Q1
$230K Buy
3,070
+611
+25% +$44.5K 0.07% 180
2020
Q4
$168K Buy
2,459
+887
+56% +$57.7K 0.05% 219
2020
Q3
$92K Sell
1,572
-63
-4% -$3.92K 0.03% 309
2020
Q2
$106K Buy
1,635
+139
+9% +$8.75K 0.03% 295
2020
Q1
$89K Buy
1,496
+3
+0.2% +$200 0.03% 278
2019
Q4
$111K Buy
1,493
+111
+8% +$7.79K 0.03% 276
2019
Q3
$88K Buy
1,382
+25
+2% +$1.48K 0.03% 299
2019
Q2
$74K Buy
1,357
+784
+137% +$42.2K 0.02% 320
2019
Q1
$31K Sell
573
-483
-46% -$29.8K 0.01% 486
2018
Q4
$69K Buy
1,056
+254
+32% +$19K 0.02% 301
2018
Q3
$63K Buy
802
+65
+9% +$4.65K 0.02% 323
2018
Q2
$47K Buy
737
+266
+56% +$17.5K 0.02% 368
2018
Q1
$29K Sell
471
-622
-57% -$44.6K 0.01% 466
2017
Q4
$79K Sell
1,093
-767
-41% -$55.8K 0.03% 272
2017
Q3
$151K Buy
1,860
+50
+3% +$3.96K 0.06% 178
2017
Q2
$146K Sell
1,810
-128
-7% -$10.1K 0.06% 175
2017
Q1
$152K Sell
1,938
-505
-21% -$40.3K 0.07% 163
2016
Q4
$193K Sell
2,443
-403
-14% -$32.6K 0.08% 159
2016
Q3
$254K Buy
2,846
+83
+3% +$7.83K 0.12% 134
2016
Q2
$265K Buy
2,763
+237
+9% +$23.6K 0.13% 124
2016
Q1
$262K Sell
2,526
-78
-3% -$7.58K 0.13% 119
2015
Q4
$255K Buy
2,604
+138
+6% +$13.5K 0.13% 123
2015
Q3
$238K Sell
2,466
-3,275
-57% -$344K 0.14% 114
2015
Q2
$602K Buy
5,741
+281
+5% +$28.7K 0.32% 69
2015
Q1
$564K Buy
5,460
+493
+10% +$49.9K 0.3% 71
2014
Q4
$479K Sell
4,967
-35
-0.7% -$3.08K 0.27% 80
2014
Q3
$398K Buy
5,002
+889
+22% +$70.1K 0.24% 95
2014
Q2
$309K Buy
4,113
+1,358
+49% +$103K 0.18% 120
2014
Q1
$206K Buy
+2,755
New +$195K 0.13% 148

Other funds holding CVS

Parkside Financial Bank & Trust's CVS Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its CVS Health (CVS) stake by 2.4% in Q1 2026, selling an estimated $9.32K and leaving 4,846 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #319.

Parkside Financial Bank & Trust first reported a position in CVS in Q1 2014 and has held it in 49 quarters since. The position peaked at $602K in Q2 2015. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Parkside Financial Bank & Trust held 4,846 shares of CVS Health worth $348K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 121 CVS Health shares in Q1 2026, an estimated $9.32K.
  • CVS Health made up 0.03% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #319 holding.
  • Parkside Financial Bank & Trust first reported a position in CVS Health in Q1 2014 and has held it in 49 quarters since.
  • Parkside Financial Bank & Trust's CVS Health position peaked at $602K in Q2 2015.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.